Biocon Gears Up for Q3 Reveal on 12th February; Check Key Expectations Here
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 11 Feb 2026 • 2:01 pm
Posted by:
Biocon Q3 results FY26 are scheduled to be announced on 12th February 2026. Financial analysts anticipate an increase in revenue due to higher sales and a significant rise in PAT.
Biocon Q3 Results 2026 Preview
- Biocon' revenue is expected to be in the range of ₹3,821.40 crore, a 6.43% YoY increase.
- Profit After Tax, or PAT, is projected to fall 2% YoY.
- Net profit is ₹25.10 crore, a fall 2% YoY
- EBITDA to rise 18.18%
Biocon Share Performance
- Over the past six months, Biocon' share price has risen by 9.02% to ₹372.95.
- Moreover, over the past year, the stock has increased by 3.02%.
- Despite this weak short-term performance, Biocon' stock has delivered a financially sound 8.60% return over the past 5 years.
- As of 11th February 2026, the stock traded at ₹372.90 per share.
Key Factors to Watch for Biocon Q3 Results FY26
- Revenue & Segment Performance: Growth in biosimilars, generics, and CRDMO businesses.
- Margins & Profitability: Trends in EBITDA and net profit amid R&D and cost pressures.
- Biosimilars Approvals & Launches: Progress in the US and Europe markets.
- R&D & Product Pipeline: Investment levels and advancement of complex biologics.
- Management Outlook: Guidance on growth, debt reduction, and future launches.
Final Thoughts
Biocon will announce its Q3 FY26 results on 12th February 2026. Analysts expect 6.43% revenue growth, a 2% fall in PAT, and a 18.18% rise in EBITDA. Biocon focuses on biosimilars development, generics and APIs, CRDMO services, R&D-driven innovation, and global market expansion.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Recent Articles
GOCL Corporation Q3 Results FY26 Preview
Godrej Industries Q3 Results FY26 Preview
Godawari Power and Ispat Q3 Results FY26 Preview
Himatsingka Seide Q3 Results FY26 Preview
Igarashi Motors India FY26 Preview
Recent Articles
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
30 October 2026
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
30 October 2026
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
30 October 2026
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
30 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Gold Price Today, 30 October 2026: MCX Gold Falls 1.25% to Rs 1,40,808 Per 10 Grams and Spot Gold Slips Below $4,000, a 3.5-Month Low, as December Fed Hike Bets Build Ahead of Dhanteras
Anthropic IPO Valuation: Aswath Damodaran Values the Claude Maker at $1.475 Trillion, Just Below the Reported $1.5 to $2 Trillion IPO Range, With Scenarios From Negative $373 Billion to $4.04 Trillion
Equitas Small Finance Bank Share Price Crashes 10% to Rs 51.25 on 30 October 2026, Down 21% in Two Days After CEO PN Vasudevan Resigns Despite Record Equitas Q2 Results: What Is Going On?
Greaves Cotton Share Price Jumps 10% Despite 81% Fall in Q2 Profit: What Is Driving the Rally?
Asian Paints Share Price After Q2 Results: Profit Up 7%, but Price Hikes Are Yet to Brighten Margins
Popular this week
Borosil Share Price Jumps 16% After Strong Q2 Results: Record Profit, Margin Jump and Key Price Levels to Know
Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times